ESR2 and breast carcinoma: This prompted us to further elucidate the functional effects of ERβ knockdown as compared to parental breast cancer cell lines with distinct ER status, as well as the in vivo tumorigenic effects of monoclonal shERβ MDA-MB-231 cell populations.